Trial Profile
Hand-foot-skin reaction in sorafenib therapy for hepatocellular carcinoma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Jul 2018
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- 29 Jul 2018 New trial record
- 18 Jul 2018 Results published in the Investigational New Drugs